A top respiratory specialist in Thailand spoke out Friday about a study in the Clinical Infectious Diseases Journal last month saying that not only does to antiviral medication Favipiravir not seem to help fight Covid-19 at all, but it can also lead to patients getting gout. Now the Department of Medical Sciences is defending the use of Favipiravir in Thailand to treat coronavirus patients, saying there were flaws in the study. The research compared data from 599 Covid patients treated with the drug to data from 588 similarly infected patients who received only a placebo pill. Participants were from the […]
The story Favipiravir: DMS says Thai Covid study contradicts US study as seen on Thaiger News.